Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles

FEBS Lett. 2012 Feb 17;586(4):459-65. doi: 10.1016/j.febslet.2012.01.032. Epub 2012 Jan 28.

Abstract

Bordetella pertussis adenylate cyclase toxin (ACT) intoxicates cells by producing intracellular cAMP. B. pertussis outer membrane vesicles (OMV) contain ACT on their surface (OMV-ACT), but the properties of OMV-ACT were previously unknown. We found that B. pertussis in the lung from a fatal pertussis case contains OMV, suggesting an involvement in pathogenesis. OMV-ACT and ACT intoxicate cells with and without the toxin's receptor CD11b/CD18. Intoxication by ACT is blocked by antitoxin and anti-CD11b antibodies, but not by cytochalasin-D; in contrast, OMV-ACT is unaffected by either antibody and blocked by cytochalasin-D. Thus OMV-ACT can deliver ACT by processes distinct from those of ACT alone.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenylate Cyclase Toxin / pharmacokinetics*
  • Adenylate Cyclase Toxin / toxicity*
  • Animals
  • Antibodies, Bacterial / administration & dosage
  • Bordetella pertussis / pathogenicity*
  • Bordetella pertussis / ultrastructure
  • CHO Cells
  • Cell Line
  • Cell Membrane / metabolism
  • Cell Membrane / ultrastructure
  • Cricetinae
  • Cricetulus
  • Cytochalasin D / pharmacology
  • Humans
  • Mice
  • Microscopy, Electron, Transmission
  • Trypsin / pharmacology
  • Whooping Cough / etiology
  • Whooping Cough / microbiology
  • Whooping Cough / pathology

Substances

  • Adenylate Cyclase Toxin
  • Antibodies, Bacterial
  • Cytochalasin D
  • Trypsin